Page 13 - Binding Affinity News Today

Researchers from the Management and Science University in Malaysia have used computational tools to investigate the new variant.

In a new study, scientists have computationally predicted the structure of the Omicron spike RBD from available sequences and explored the dynamics of antigen-antibody interactions.

The current study not only analyses the mutations in the Omicron spike variant but classifies various combinations of spike mutations into groups.

A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.

Researchers conducted a study on COVID-19 convalescent patients and post-vaccinated populations to identify the minimal levels of antibody required to protect against SARS-CoV-2 infection.

/PRNewswire/ -- The "Global Constrained Peptide Drugs Market: Focus on Peptide Type, Product, and Country Analysis - Analysis and Forecast, 2023-2031" report...

/PRNewswire/ -- The "Global Constrained Peptide Drugs Market: Focus on Peptide Type, Product, and Country Analysis - Analysis and Forecast, 2023-2031" report...

Researchers have been investigating the changes in receptor binding in these variants that increase the danger they pose.

Scientists have recently focused on the development of plant-based recombinant protein platforms.

In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.